Rashtriya Newsflash

Clostridioides Difficile Infection Market Size in the 7MM was ~USD 500 million in 2024 and It is expected to increase by 2034, estimates DelveInsight

Clostridioides Difficile Infection Market Size in the 7MM was ~USD 500 million in 2024 and It is expected to increase by 2034, estimates DelveInsight

DelveInsight’s “Clostridioides Difficile Infection Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Clostridioides Difficile Infection, historical and forecasted epidemiology as well as the

Read Full Article

Triple Negative Breast Cancer Market Set for Robust Growth Through 2034Innovative therapies and rising incidence drive steady expansion across the US, Europe, and Japan

Triple Negative Breast Cancer Market Driven by rise of immunotherapies, antibody-drug conjugates, and precision-targeted approaches, TNBC market is projected to expand from USD 4.7 billion in 2025 to USD 7.1

Read Full Article

Limb Girdle Muscular Dystrophy Therapeutics Market Size in the 7MM is expected to increase substantially by 2034, estimates DelveInsight

DelveInsight’s ” Limb Girdle Muscular Dystrophy Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of Limb Girdle Muscular Dystrophy, historical and forecasted epidemiology, as well

Read Full Article

Non-Cystic Fibrosis Bronchiectasis Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA Approvals, Future Outlook by DelveInsight

Non-Cystic Fibrosis Bronchiectasis Competitive Landscape Non-Cystic Fibrosis Bronchiectasis companies working in the treatment market are NovaBiotics Ltd, Synspira Therapeutics, Parion Sciences, Chiesi Farmaceutic, CSL Behring, Haisco Pharmaceutical, SolAeroMed Inc., AstraZeneca,

Read Full Article

Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) Market Analysis 2034 – Competitive Landscape, Clinical Trials, Market Share, Therapies, Prevalence, Companies by DelveInsight

Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) Market Potential Pulmonary Hypertension Associated with Interstitial Lung Disease Therapies are TPIP,

Read Full Article

Triple-Negative Breast Cancer Market Analysis 2034 – Competitive Landscape, Clinical Trials, Market Share, Therapies, Prevalence, and Key Players by DelveInsight

Triple-Negative Breast Cancer Market Leading triple-negative breast cancer companies such as G1 Therapeutics, Daiichi Sankyo, AstraZeneca, Zenith Epigenetics, Pfizer, OncoPep,

Read Full Article

Roy M Arceroldan Inspires Curiosity and Healing Through Words in His Book Beginnings of a Code Breaker

In Beginnings of a Code Breaker, author Roy M. Arceroldan invites readers into a world where language holds deeper meaning

Read Full Article

Alfa Chemistry Unveils Expanded Line of Polymer Microspheres for Innovative Research and Manufacturing

Expanded Line Features Improved Size Distribution, Enhanced Surface Functionalization, and New Polymer Types. New York, USA – October 28, 2025

Read Full Article

Huntington’s Disease | Clinical Landscape, Key Companies, Therapeutic Assessment, Treatment Algorithms, and Pipeline Insights – featuring leading players such as Hoffmann-La Roche, PTC Therapeutics, A

Huntington’s Disease Clinical Trials DelveInsight’s, “Huntington’s Disease – Pipeline Insight, 2025” report provides comprehensive insights about 20+ companies and 20+

Read Full Article

Hyperuricemia: Clinical Overview, Company Landscape, Therapeutic Evaluation, Treatment Strategies, and Pipeline Analysis | Key Players: Arthrosi Therapeutics, Shanton Pharma Pte. Ltd., Jiangsu Atom Bi

Hyperuricemia Clinical Trials DelveInsight’s, “Hyperuricemia – Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs

Read Full Article